Does CLOPIDOGREL BISULFATE Cause Malignant neoplasm progression? 33 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Malignant neoplasm progression have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.1% of all adverse event reports for CLOPIDOGREL BISULFATE.
33
Reports of Malignant neoplasm progression with CLOPIDOGREL BISULFATE
0.1%
of all CLOPIDOGREL BISULFATE reports
15
Deaths
22
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CLOPIDOGREL BISULFATE?
Of the 33 reports, 15 (45.5%) resulted in death, 22 (66.7%) required hospitalization, and 6 (18.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?
Gastrointestinal haemorrhage (5,513)
Anaemia (3,043)
Dyspnoea (1,963)
Drug interaction (1,846)
Haemorrhage (1,762)
Drug ineffective (1,644)
Cerebral haemorrhage (1,603)
Dizziness (1,586)
Epistaxis (1,560)
Melaena (1,547)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CLOPIDOGREL BISULFATE Alternatives Have Lower Malignant neoplasm progression Risk?
CLOPIDOGREL BISULFATE vs CLORAZEPATE
CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN
CLOPIDOGREL BISULFATE vs CLOTHIAPINE
CLOPIDOGREL BISULFATE vs CLOTIAZEPAM
CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE